Resveratrol is cidal to both classes of Haemophilus ducreyi

International Journal of Antimicrobial Agents

Volumn 41, Issue 5, 2013, Pages 477-479

  Nawrocki, Erin M ^a   Bedell, Hillary W ^a   Humphreys, Tricia L ^a  

^a ALLEGHENY COLLEGE   (United States)

Author keywords

Chancroid; Haemophilus ducreyi; Lactobacillus; Microbicide; Resveratrol

Indexed keywords

MICROBICIDE; RESVERATROL;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL STRAIN; BACTERICIDAL ACTIVITY; BACTERIOSTASIS; BACTERIUM CULTURE; COCULTURE; DRUG CONCENTRATION; DRUG DETERMINATION; HAEMOPHILUS DUCREYI; LACTOBACILLUS; MINIMUM CIDAL CONCENTRATION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PLANT DISEASE; PLANT RESPONSE; PRIORITY JOURNAL; ULCUS MOLLE; VAGINA FLORA;

ANTI-BACTERIAL AGENTS; HAEMOPHILUS DUCREYI; HUMANS; LACTOBACILLUS; MICROBIAL VIABILITY; STILBENES;

EID: 84876290184     PISSN: 09248579     EISSN: 18727913     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2013.02.008     Document Type: Article

References (15)

1. B.C. Trela, and A.L. Waterhouse Resveratrol: isomeric molar absorptivities and stability J Agric Food Chem 5 1996 1253 1257
2. L. Paulo, S. Ferreira, E. Gallardo, J.A. Queiroz, and F. Domingues Antimicrobial activity and effects of resveratrol on human pathogenic bacteria World J Microbiol Biotechnol 26 2010 1533 1538
3. S. Martini, C. Bonechi, C. Rossi, and N. Figura Increased susceptibility to resveratrol of Helicobacter pylori strains isolated from patients with gastric carcinoma J Nat Prod 74 2011 2257 2260
4. H. Jung, I. Hwang, W. Sung, H. Kang, B. Kang, and Y. Seu Fungicidal effect of resveratrol on human infectious fungi Arch Pharm Res 28 2005 557 560
5. J.J. Docherty, M.M. Fu, J.M. Hah, T.J. Sweet, S.A. Faith, and T. Booth Effect of resveratrol on herpes simplex virus vaginal infection in the mouse Antiviral Res 67 2005 155 162
6. D.M. Janowicz, S. Ofner, B.P. Katz, and S.M. Spinola Experimental infection of human volunteers with Haemophilus ducreyi: fifteen years of clinical data and experience J Infect Dis 199 2009 1671 1679
7. C.D. White, I. Leduc, B. Olsen, C. Jeter, C. Harris, and C. Elkins Haemophilus ducreyi outer membrane determinants, including DsrA, define two clonal populations Infect Immun 73 2005 2387 2399
8. P. Mayaud, and D. McCormick Interventions against sexually transmitted infections (STI) to prevent HIV infection Br Med Bull 58 2001 129 153
9. M. Motley, S.K. Sarafian, J.S. Knapp, A.A. Zaidi, and G. Schmid Correlation between in vitro antimicrobial susceptibilities and β-lactamase plasmid contents of isolates of Haemophilus ducreyi from the United States Antimicrob Agents Chemother 36 1992 1639 1643
10. US Centers for Disease Control and Prevention (CDC). Sexually transmitted diseases treatment guidelines, 2010. Diseases characterized by genital, anal, or perianal ulcers. Atlanta, GA: CDC; 2011. http://www.cdc.gov/std/treatment/ 2010/genital-ulcers.htm#chancroid [accessed 20.02.13].
11. B.J. Moncla, and S.L. Hillier Why nonoxynol-9 may have failed to prevent acquisition of Neisseria gonorrhoeae in clinical trials Sex Transm Dis 32 2005 491 494
12. B. Ma, L.J. Forney, and J. Ravel Vaginal microbiome: rethinking health and disease Annu Rev Microbiol 66 2012 371 389
13. J.J. Docherty, M.M. Fu, and M. Tsai Resveratrol selectively inhibits Neisseria gonorrhoeae and Neisseria meningitidis J Antimicrob Chemother 47 2001 243 244
14. L.M. Ballweber, J.E. Jaynes, W.E. Stamm, and M.F. Lampe In vitro microbicidal activities of cecropin peptides D2A21 and D4E1 and gel formulations containing 0.1 to 2% D2A21 against Chlamydia trachomatis Antimicrob Agents Chemother 46 2002 34 41
15. M.K. Stafford, H. Ward, A. Flanagan, I.J. Rosenstein, D. Taylor-Robinson, and J.R. Smith Safety study of nonoxynol-9 as a vaginal microbicide: evidence of adverse effects J Acquir Immune Defic Syndr Hum Retrovirol 17 1998 327 331